Cagrilintide + Tirzepatide Clinical Evidence Context Direct stack evidence No published human trial has tested cagrilintide + tirzepatide together
Injectable (Peptide Form): Most recommended and effective form as it works for overall health, including cellular health, tissue repair and longevity support
Hair follicle research has documented that GHK-Cu increases follicle size, stimulates hair growth in organ culture models, and extends the anagen (growth) phase of the hair cycle
Topical protocol guidance Apply GHK-Cu serum or cream once to twice daily, to clean dry skin For anti-aging use: apply after cleansing, before moisturizer Allow 15-20 minutes before applying other actives Best results typically emerge after consistent use over 8-12 weeks Do not combine in the same session with strong vitamin C serums, AHAs, or retinoids Post-procedure use: apply after microneedling, laser, or peel procedures as directed by the provider Injectable protocols general reference Safety profile of GHK-Cu GHK-Cu has one of the best safety profiles of any peptide studied for aesthetic and regenerative use
, Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation, J